Lyell Immunopharma, Inc.(LYEL)内部人交易:高管与董事近期交易
过去 18 个月,共有 22 位内部人为 Lyell Immunopharma, Inc.(LYEL)报告了 86 笔 Form 4 交易(最近一笔 2026-11-12)。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-11-12 | Seely Lynn | President and CEO | 卖出 | 545 | $8,682 |
| 2026-11-12 | Hill Stephen J. | Chief Operating Officer | 卖出 | 88 | $1,402 |
| 2026-11-12 | Lee Gary K. | Chief Scientific Officer | 卖出 | 129 | $2,055 |
| 2026-11-12 | Bulis Veronica Sanchez | VP, Corporate Controller | 卖出 | 416 | $6,627 |
| 2026-11-05 | ARCH Venture Partners IX Overage, L.P. | 10% 以上股东 | 买入 | 2.3M | $25.0M |
| 2026-11-05 | CRANDELL KEITH | 10% 以上股东 | 买入 | 2.3M | $25.0M |
| 2026-11-05 | NELSEN ROBERT | 10% 以上股东 | 买入 | 2.3M | $25.0M |
| 2026-11-05 | BYBEE CLINTON | 10% 以上股东 | 买入 | 2.3M | $25.0M |
| 2026-11-05 | GILLIS STEVEN | 10% 以上股东 | 买入 | 2.3M | $25.0M |
| 2026-11-05 | Burow Kristina | 10% 以上股东 | 买入 | 2.3M | $25.0M |
| 2026-11-05 | ARCH Venture Fund IX, L.P. | 10% 以上股东 | 买入 | 2.3M | $25.0M |
| 2026-11-05 | ARCH Venture Fund IX Overage, L.P. | 10% 以上股东 | 买入 | 2.3M | $25.0M |
| 2026-11-05 | BERNS PAUL L | 10% 以上股东 | 买入 | 2.3M | $25.0M |
| 2026-11-05 | ARCH Venture Partners IX, L.P. | 10% 以上股东 | 买入 | 2.3M | $25.0M |
| 2026-11-05 | ARCH Venture Partners IX, LLC | 10% 以上股东 | 买入 | 2.3M | $25.0M |
| 2026-11-05 | ARCH Venture Fund XIII, L.P. | 10% 以上股东 | 买入 | 2.3M | $25.0M |
| 2026-11-05 | ARCH Venture Partners XIII, LLC | 10% 以上股东 | 买入 | 2.3M | $25.0M |
| 2026-11-05 | ARCH Venture Partners XIII, L.P. | 10% 以上股东 | 买入 | 2.3M | $25.0M |
| 2026-10-13 | Aguirre Jarrad Mattieu | Chief Medical Officer | 卖出 | 422 | $3,642 |
| 2026-09-10 | Shook David | Chief Medical Officer | 卖出 | 500 | $6,350 |
| 2026-08-25 | Seely Lynn | President and CEO | 卖出 | 9,589 | $149,013 |
| 2026-08-25 | Hill Stephen J. | Chief Operating Officer | 卖出 | 989 | $15,369 |
| 2026-08-25 | Lee Gary K. | Chief Scientific Officer | 卖出 | 1,457 | $22,642 |
| 2026-08-11 | Hill Stephen J. | Chief Operating Officer | 卖出 | 89 | $1,276 |
| 2026-08-11 | Seely Lynn | President and CEO | 卖出 | 390 | $5,593 |
来源:SEC Form 4 申报文件 · 截至 2026-11-12